000 | 01972 a2200589 4500 | ||
---|---|---|---|
005 | 20250516171847.0 | ||
264 | 0 | _c20131223 | |
008 | 201312s 0 0 eng d | ||
022 | _a1095-564X | ||
024 | 7 |
_a10.1016/j.ydbio.2013.09.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Yang | |
245 | 0 | 0 |
_aInactivation of Cdc42 in neural crest cells causes craniofacial and cardiovascular morphogenesis defects. _h[electronic resource] |
260 |
_bDevelopmental biology _cNov 2013 |
||
300 |
_a239-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActins _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Morphogenetic Protein 2 _xpharmacology |
650 | 0 | 4 |
_aCardiovascular Abnormalities _xembryology |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCraniofacial Abnormalities _xembryology |
650 | 0 | 4 | _aCrosses, Genetic |
650 | 0 | 4 |
_aCytoskeleton _xmetabolism |
650 | 0 | 4 |
_aEmbryo, Mammalian _xabnormalities |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMorphogenesis _xdrug effects |
650 | 0 | 4 |
_aNeural Crest _xdrug effects |
650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPseudopodia _xdrug effects |
650 | 0 | 4 |
_aThymus Gland _xabnormalities |
650 | 0 | 4 |
_acdc42 GTP-Binding Protein _xmetabolism |
700 | 1 | _aJin, Yixin | |
700 | 1 | _aLi, Jieli | |
700 | 1 | _aSeto, Edward | |
700 | 1 | _aKuo, Enoch | |
700 | 1 | _aYu, Wei | |
700 | 1 | _aSchwartz, Robert J | |
700 | 1 | _aBlazo, Maria | |
700 | 1 | _aZhang, Shenyuan L | |
700 | 1 | _aPeng, Xu | |
773 | 0 |
_tDevelopmental biology _gvol. 383 _gno. 2 _gp. 239-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ydbio.2013.09.013 _zAvailable from publisher's website |
999 |
_c23107524 _d23107524 |